Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Status: OpinionHuman medicines European public assessment report (EPAR): Etcamah, camizestrant, Status: OpinionHuman medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Status: OpinionHuman medicines European public assessment report (EPAR): Vijoice, alpelisib, Status: OpinionHuman medicines European public assessment report (EPAR): Liraglutide STADA, liraglutide, Status: Opinion